Contraindications of incretin therapy: difference between revisions
Diff·revision 8 → 9·19:45, 23 Feb 2025
Difference between revision 8 and revision 9 of Contraindications of incretin therapy. 1 line changed; the page grew by 34 bytes.
| Revision 8 — 03:07, 2 Feb 2025 ResinRhoswen (talk) correct the renal statement — the caution is about volume depletion 3,374 bytes +721 | Revision 9 — 19:45, 23 Feb 2025 Chromatokid (talk) move a stray full stop inside the reference 3,408 bytes +34 | ||
|---|---|---|---|
| 1 | {{Infobox concept | 1 | {{Infobox concept |
| 2 | | name = Contraindications of incretin therapy | 2 | | name = Contraindications of incretin therapy |
| + | 3 | | subtitle = Clinical practice | |
| 3 | | Absolute, labelled = Personal or family history of medullary thyroid carcinoma; MEN 2 | 4 | | Absolute, labelled = Personal or family history of medullary thyroid carcinoma; MEN 2 |
| 4 | | Also labelled = Prior hypersensitivity to the product | 5 | | Also labelled = Prior hypersensitivity to the product |